Oral Dispersible Tablets
All Geoplan products are formulated as oral dispersible tablets, providing enhanced convenience as they eliminate difficulties associated with swallowing. They ensure superior ingredients’ absorption, as tablets gradually dissolve in the mouth, enabling rapid bioavailability and increased effectiveness.
Unique ingredient combinations
New product development is guided by the selection of unique ingredient combinations, with a primary emphasis on the synergistic action of active compounds. This approach is designed to maximize the efficacy of the final product, ensuring market differentiation and high value-added products. Cutting-edge technologies and innovative concepts are continuously evaluated in order to enhance the bioavailability of active ingredients, while the most suitable raw materials are carefully selected to achieve this objective. Furthermore, a comprehensive analysis of market trends and consumer health needs informs the product development process, enabling the design of scientifically validated solutions that align with contemporary health and wellness demands.
Patents and Intellectual Property (IP) Protection
The distinctiveness of our formulations is safeguarded through patents issued by the Hellenic Industrial Property Organization (OBI) – the exclusive authority in Greece responsible for the protection of intellectual property in the field of innovations. These patents are issued for innovations that meet strict criteria for novelty, innovative advancement and industrial applicability. Through this process, we ensure the protection of our proprietary formulations and advanced technologies, securing exclusive rights for their manufacturing and commercialization.
Oral dispersible tablet compositions with vitamin D3 and vitamin B12
The present invention (Number 1010820) describes a new composition comprising two active ingredients, Cholecalciferol (vitamin D3) and Methylcobalamin (vitamin B12) in the form of an oral dispersible tablet, in suitable concentrations for enhanced absorption through the mucous membranes in the mouth, with the aim of restoring the deficiency or lack of vitamins D3 and B12.
Oral dispersible tablet compositions with probiotics, Zinc and vitamin C
The present invention (Number 1010840) describes a novel composition comprising a spore-forming probiotic and the nutrients zinc and vitamin C in the form of an oral dispersible tablet, in appropriate concentrations for enhanced absorption. The purpose is to restore the deficiency or lack of zinc and vitamin C and to restore the balance of the intestinal microbiome.